Market Overview
The Global Stem Cell Market is projected to reach a value of USD 15.4 billion in 2023 & USD 38.1 billion in 2032 at a CAGR of 10.6% during the forecast period of 2023 to 2032.
The global stem cell market mainly concentrates on making treatments with stem cells for diseases like cancer, heart issues, and muscle problems. It also helps in rare health conditions. Stem cell therapy is often used in medicine to help people heal. It uses live human blood cells (stem cells, lymphocytes, and dendritic cells).
These are helpful in treating long-term as well as sudden diseases that don't happen very often. This market has a lot of cell stuff like stem treatments, CAR-T healing therapies, and tissue-made things. These are all created for patients suffering from special health issues and conditions.
Market Dynamic
Many factors affect how the world's stem cell market will work. This includes factors that change when and where new treatment plans using cells will come out in hospitals or other healthcare places. A few vital things making this market big are the increasing investment in stem cell studies and the rising number of people found with long-term sicknesses. New technology in this market, like CRISPR gene changing, makes it better for healthcare professionals to handle stem cells and help with treatments.
But this market is also affected by ethical worries and problems with many rules and regulations that are set up for the monitoring of this market. As people learn more about stem cells and experiments continue, the global stem cell market is expected to steadily grow in the near future as well. This will provide life-changing help in healthcare and treatments that start again. The increase in research places, hospitals, and the healthcare sector makes the worldwide stem cell market grow.
It is because they are changing focus to make safer, better working medical treatments for rare diseases that could change how we treat illnesses now. Organizations like the CDC, WHO, and FDA in the United States plus others around the world help shape this market. They approve and assess stem cell-based therapies before they are released on the market. The studies and tests done on stem cells greatly impact the worldwide market for therapies.
Research Scope and Analysis
By Product
In the context of products developed using stem cells, Adult Stem Cells (ASCs) dominate this segment as they hold 85.1% of the market share in 2023 and are forecasted to show significant growth in the upcoming years of 2023 to 2032.
Adult stem cells are in found in many parts of the human body, like bone marrow, fat tissue, and brain tissue. Because human bodies have easy-to-get stem cells, they are better and more useful for healing treatments. Hematopoietic and mesenchymal stem cells are significantly contributing to the growth of this market in regenerative medicine.
They're having good results with different tests on humans. Usually, stem cells from the bone marrow are used during transplantation. Meanwhile, mesenchymal ones have a big possibility of helping with body parts like bones where they can show lots of progress.
Moreover, adult stem cells are generally considered secure as the treatment plan they are well-tolerated when used in therapeutic interventions, where they reduce the concerns regarding tumorigenicity and other safety issues associated with the use of pluripotent stem cells in treatment. This successful implementation of stem cells in regenerative medicine has fueled the investment in the development of this market which is now acting as a major factor behind the success of this market.
By Therapy
Allogeneic stem cell therapy shows dominance within the stem cell therapy segment as it holds the highest market share in 2023 and is projected to show subsequent growth in the forecasted years of 2023 to 2032. Allogeneic stem cell therapy is highly popular in this market and dominates this segment as it uses stem cells derived from donors which offer a high applicability compared to autologous stem therapy, where cells come from the patient. This broader donor pool facilitates easier access to a diverse range of stem cells, making allogeneic therapy available to a larger patient population.
Allogeneic therapies are often termed off-the-shelf, which means that they can be prepared in advance before treatment so that they can used when needed. The off-the-shelf nature of allogeneic therapy streamlines the treatment process and reduces waiting times for patients. Unlike autologous therapy, allogeneic therapy doesn't require patients to undergo invasive procedures for cell harvesting which highly reduces patient burden and can lead to higher patient acceptance and compliance.
The manufacturing process for allogeneic therapies is generally more straightforward and scalable compared to autologous therapies. The ability to produce larger quantities of consistent, quality-controlled products supports mass production and distribution.
By Application
Based on application, Regenerative medicine dominates this segment as it holds 89.1% of the market share in 2023 and is expected to show following growth in the forthcoming period of 2023 to 2032 as well. The dominance of regenerative medicine in the global stem cell market can be attributed to its high potential in treating a wide range of patients suffering from chronic medical conditions and rare diseases. Stem cells offer various cell types of therapies which, makes them valuable for regenerating damaged tissues & organs.
This healing capability of the stem cellular has brought about improved recognition and investment in regenerative medicine. Stem mobile-primarily based regenerative remedies offer a brand new manner to deal with sufferers stricken by degenerative illnesses, which includes cardiovascular disorders, neurological conditions and orthopaedic troubles. The ongoing research concerning the improvement of cellular therapy ends in the discovery of latest formulations and methods so as to appreciably impact the growth of this marketplace.
These ongoing research and technological advancements in stem cell therapy tactics are prominently expanding the competencies and application of this medical and healthcare zone.
Additionally, within the previous couple of years stem cellular market has visible a sudden growth in medical trials exploring the safety and efficacy of stem cellular-based totally cures. Successful trials and regulatory approvals for certain regenerative medicine products have improved self-belief in the feasibility and capability success of these remedies.
The Stem Cell Market Report is segmented on the basis of the following:
By Product
- Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Epithelial
- Others
- Human Embryonic Stem Cells (HESCs)
- Induced Pluripotent Stem Cells (iPSCs)
- Very Small Embryonic Like Stem Cells
By Therapy
- Allogenic Stem Therapy
- Autologous Stem Therapy
By Application
- Regenerative Medicine
- Drug Discovery & Development
Regional Analysis
In 2023, North America dominated the global stem cell market with a market share of 44.8% in 2023. It's expected to grow even more by 2032. The area's control of the stem cell market is because it has a good environment that supports top-notch health care facilities. This helps in making and studying different treatments using stem cells.
This area also has some big research places and schools like John Hopkins University, Harvard University, and more.
They are leaders in studying ways to use stem cells but they're also helping a lot with how this market is growing. Government bodies like the U.S. Food and Drug Administration (FDA) have made ways for treatments using stem cell therapy to be produced and approved. The government helps this market, making sure businesses and investors feel safe about putting money into that area. The big healthcare system in North America, its strong research skills, support from rules, and early use of stem cells have made it a top place in the worldwide market for stem cells.
Many major players in the stem cell market, including prominent biotechnology and pharmaceutical companies, are headquartered in North America and have a significant presence in the world market. This concentration of industry leaders contributes to the region's dominance. These elements together make this area important for the growth of the worldwide stem cell market.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The competitive scenario in the global stem cell market marks intense competition among key players vying for market share and gaining a competitive edge over others This market sees pharmaceutical companies, biotechnology companies, academic research institutes and businesses a collaborative startup. The global stem cell market features key players such as Mesoblast Ltd., Thermo Fisher Scientific, and StemCells Inc., which are at the forefront of the global stem cell market as they are heavily investing in research and development of a new product catalog.
These companies exhibit a diverse range of products and technologies, contributing to a dynamic competitive landscape. Market leaders maintain a significant presence globally, with strategic alliances, partnerships, and a commitment to research & development.
Emerging players in the stem cell market also play a crucial role, introducing fresh perspectives and contributing to the evolving landscape.
The stem cell market, marked by continuous research and therapeutic breakthroughs, demands a nuanced understanding of the strategies and strengths that define the competition among key industry participants. There are many instances when the research is translated into clinical operations and is commercialized.
Some of the prominent players in the Global Stem Cell Market are:
- CellGenix GmbH
- PromoCell Gmb
- Kite Pharma
- Advanced Cell Technology Inc.
- STEMCELL Technologies Inc.
- Cellular Engineering Technologies Inc.
- Lonza
- Cellartis AB
- Angel Biotechnology
- Brainstorm Cell Therapeutics
- Celgene Corporation
- Osiris Therapeutics
- Genea Biocells
- Bioheart Inc.
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Stem Cell Market:
The global stem cell market did well during the COVID-19 time as it showed how using stem cells can help fight the new virus. This also got the notice of many health researchers during the COVID-19 pandemic, making them do more medical tests and experiments using stem cells for treatment. Regenerative medicine, stem cells for treatment, has become a hopeful choice for patients. This is because it can lower death rates and germ infection numbers.
Especially during the pandemic, this market watched companies working with research institutes. They focused on making new treatments for COVID-19 like when the Infectious Disease Research Institute teamed up with Cellularity to help find cures. In April 2020, they said that the US FDA approved a test study plan. This will help make treatments for COVID-19 using cells better. So, as more clinical trials are needed, the demand for stem cells is expected to grow a lot during the time we're looking at.
Report Details
| Report Characteristics |
| Market Size (2023) |
USD 15.4 Bn |
| Forecast Value (2032) |
USD 38.1 Bn |
| CAGR (2023-2032) |
10.6% |
| Historical Data |
2017 - 2022 |
| Forecast Data |
2023 - 2032 |
| Base Year |
2022 |
| Estimate Year |
2023 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Product (Adult Stem Cells (ASCs), Human
Embryonic Stem Cells (HESCs), Induced Pluripotent
Stem Cells (iPSCs) and Very Small Embryonic Like
Stem Cells), By Therapy (Allogenic Stem Therapy and
Autologous Stem Therapy), By Application
(Regenerative Medicine and, Drug Discovery &
Development) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Cellular Engineering Technologies Inc., CellGenix
GmbH, PromoCell Gmb, Advanced Cell Technology
Inc., STEMCELL Technologies Inc., Kite Pharma, Lonza,
Cellartis AB, Angel Biotechnology, Brainstorm Cell
Therapeutics, Celgene Corporation, Osiris
Therapeutics, Genea Biocells, Bioheart Inc., and
Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Stem Cell Market is projected to reach a value of 15.4 billion in 2023.
The Global Stem Cell Market is anticipated to grow with a CAGR (Compound annual growth rate) of
10.6% during the forecast period (2023-2032).
North America dominates the Global Stem Cell Market with 44.8% of the total revenue share in 2023.
Some of the prominent players Global Stem Cell Market include Advanced Cell Technology Inc.,
STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, PromoCell Gmb,
Kite Pharma, Lonza, Cellartis AB and others.